Since its identification in China in December 2019, the novel coronavirus COVID-19 has rapidly evolved into a pandemic. COVID-19 manifests with non-specific respiratory symptoms of variable severity and may require advanced respiratory support. The diagnosis of COVID-19 is currently confirmed by laborato...
This document provides rapid advice on the use of medical masks in communities, at home and at healthcare facilities in areas that have reported outbreaks caused by the 2019 novel coronavirus (2019-nCoV). It is intended for public health and infection prevention and control (IPC) professionals, healthcar...
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people livin...
The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing of patients who meet the definition of suspected case of pneumonia associated with a novel coronavirus identified in Wuhan, China....
This is the first edition of guidance on infection prevention and control (IPC) strategies for use when infection with a novel coronavirus (2019-nCoV) is suspected. It has been adapted from WHO’s Infection prevention and control during health care for probable or confirmed cases of Middle East respirat...
WHO has developed this interim guidance to meet the need
for recommendations on safe home care for patients with
suspected COVID-19 who present with mild symptoms
a
and
on public health measures related to the management of their
contacts.
This document was adapted from the interim guidance on
Middle Eas...
This document is intended for clinicians taking care of hospitalised adult and paediatric patients with severe acute respiratory infection (SARI) when a nCoV infection is suspected. It is not meant to replace clinical judgment or specialist consultation but rather to strengthen clinical management of the...
Lindner, Andreas K;
Lejon, Veerle;
Chappuis, François;
Seixas, Jorge;
Kazumba, Leon;
Barrett, Michael P;
Mwamba, Erick;
Erphas, Olema;
Akl, Elie A;
Villanueva, Gemma;
Bergman, Hanna;
Simarro, Pere;
Ebeja, Augustin Kadima;
Priotto, Gerardo;
Franco, Jose Ramon.
Human African trypanosomiasis caused by Trypanosoma brucei gambiense is a parasitic infection that usually progresses to coma and death unless treated. WHO has updated its guidelines for the treatment of this infection on the basis of independent literature reviews and using the Grading of Recommendation...
A paucity of scientific evidence exists on how to best treat pregnant or breastfeeding women with suspected or confirmed Ebola virus disease (EVD). Historical reports suggest that, among women who acquire EVD during pregnancy, there is increased mortality and morbidity, and a near 100% rate of adverse pr...
The Democratic Republic of Congo is currently experiencing the second largest Ebola
outbreak in history, following a 2014-2016 outbreak in western Africa that had an estimated 28,000 cases. Investigational treatment and vaccination trials are ongoing, but data in the context of pregnancy and breastfeedin...
